Lakeshore Biopharma Co Ltd (LSB) Inventory Turnover Ratio, from fourth quarter 2024 to fourth quarter 2023, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Lakeshore Biopharma Co Ltd  (NASDAQ: LSB)
 

Lakeshore Biopharma Co Ltd Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Lakeshore Biopharma Co Ltd's inventory turnover ratio, the ratio that measures Lakeshore Biopharma Co Ltd's ability to manage its supply chain, sequentially decreased to 0.61 in the fourth quarter 2024, which does not come as a surprise, as the Lakeshore Biopharma Co Ltd continue to experience headwinds, which also impact its supply chain. Lakeshore Biopharma Co Ltd's average inventory processing period in the Mar 31 2024 quarter, has increased to 598 days, from 440 days, in the 0 quarter.

Within Healthcare sector 377 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 0 in the third quarter 2024, to 1662.

LSB Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Lakeshore Biopharma Co Ltd Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LSB Inventory Turnover Ratio (Mar 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Mar 31 2023)
IV. Quarter
Y / Y Inventory Growth 5.3 % 6.28 % 6.28 % 6.28 % 90.02 %
Y / Y Cost of Sales Growth -25.68 % - - - -
Inventory Turnover Ratio (TTM) 0.61 - - - 0.87
LSB's Total Ranking # 1662 # 0 # 0 # 0 # 0
Average inventory processing period 599 - - - 420
Seq. Inventory Growth -20.35 % 0 % 0 % 32.2 % -19.61 %
Seq. Cost of Sales Growth - - - - -




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 124
Healthcare Sector # 378
Overall Market # 1662

Inventory Turnover Ratio Statistics
High Average Low
0.76 0.71 0.66
(Mar 31 2024)   (Mar 31 2025)



LSB Company Profile >> Back to LSB Efficiency Comparisons >> Compare LSB Inventory Turnover Ratio to its Competitors

Financial Statements
Lakeshore Biopharma Co Ltd's Inventories $ 23 Millions Visit LSB's Balance sheet
Lakeshore Biopharma Co Ltd's Cost of Revenues TTM $ 17 Millions Visit LSB's Income Statement
What are LSB's Sales? Visit LSB's Sales by Segment

Other Inventory Turnover Ratios
Lakeshore Biopharma Co Ltd's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
LSB's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for LSB's Competitors
Inventory Turnover Ratio for LSB's Suppliers
Inventory Turnover Ratio for LSB's Customers

You may also want to know
LSB's Sales Growth Rates LSB's Pe Price to earnings ratio LSB's Receivables Turnover Ratio LSB's Stock Quote
LSB's Net Income Growth Rates LSB's Ps Price to Sales ratio LSB's Sales per Employee LSB's Asset Turnover Ratio
LSB's Net Margin LSB's Pb Price to Book ratio LSB's Financial Strength Ratios LSB's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2024 Inventories at quarter ending Mar 31 2024
Lifecore Biomedical Inc   1.99 $ 81.127  Millions$ 41  Millions
Axsome Therapeutics Inc   1.99 $ 24.806  Millions$ 12  Millions
Rxsight Inc   1.97 $ 35.877  Millions$ 18  Millions
Accelerate Diagnostics Inc   1.94 $ 7.394  Millions$ 4  Millions
Accuray Incorporated  1.92 $ 287.614  Millions$ 150  Millions
Aytu Biopharma Inc  1.91 $ 23.989  Millions$ 13  Millions
Silk Road Medical Inc   1.91 $ 48.474  Millions$ 25  Millions
Bausch and Lomb Corp  1.90 $ 1,692.000  Millions$ 889  Millions
Pacira Biosciences inc   1.90 $ 185.298  Millions$ 97  Millions
Nature s Sunshine Products inc   1.90 $ 124.308  Millions$ 65  Millions
Allurion Technologies Inc   1.90 $ 9.805  Millions$ 5  Millions
Bioventus Inc   1.88 $ 180.000  Millions$ 96  Millions
Vertex Pharmaceuticals Inc  1.88 $ 1,337.900  Millions$ 711  Millions
Outset Medical Inc   1.88 $ 92.960  Millions$ 49  Millions
Biolife Solutions Inc   1.87 $ 71.738  Millions$ 38  Millions
Orthofix Medical Inc   1.87 $ 258.575  Millions$ 138  Millions
Avanos Medical Inc   1.86 $ 295.300  Millions$ 158  Millions
Boston Scientific Corporation  1.86 $ 4,514.000  Millions$ 2,425  Millions
Immucell Corporation  1.85 $ 13.838  Millions$ 7  Millions
Dr Reddy s Laboratories Limited  1.84 $ 1,402.778  Millions$ 763  Millions
Nephros Inc   1.83 $ 4.414  Millions$ 2  Millions
Lifeloc Technologies Inc   1.81 $ 5.379  Millions$ 3  Millions
Glaukos Corp  1.80 $ 76.929  Millions$ 43  Millions
Biotricity Inc   1.79 $ 3.919  Millions$ 2  Millions
Cerus Corporation  1.77 $ 72.313  Millions$ 41  Millions
Integra Lifesciences Holdings Corp  1.77 $ 670.901  Millions$ 378  Millions
Ani Pharmaceuticals Inc  1.77 $ 192.962  Millions$ 109  Millions
Y mabs Therapeutics inc   1.76 $ 11.380  Millions$ 6  Millions
Alpha Pro Tech Ltd   1.76 $ 37.182  Millions$ 21  Millions
Conmed Corporation  1.76 $ 568.660  Millions$ 323  Millions

Date modified: 2026-10-07T00:41:52+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.